These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12868510)
1. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510 [No Abstract] [Full Text] [Related]
2. On the association between valproate and polycystic ovary syndrome: a response and an alternative view. Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144 [No Abstract] [Full Text] [Related]
15. Polycystic ovary syndrome in women using valproate: a review. Bilo L; Meo R Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099 [TBL] [Abstract][Full Text] [Related]
16. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. Rasgon NL; Altshuler LL; Gudeman D; Burt VK; Tanavoli S; Hendrick V; Korenman S J Clin Psychiatry; 2000 Mar; 61(3):173-8. PubMed ID: 10817101 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy. Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930 [TBL] [Abstract][Full Text] [Related]
18. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324 [TBL] [Abstract][Full Text] [Related]
19. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Reynolds MF; Sisk EC; Rasgon NL Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126 [TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]